ZWHC:CA:TSX-BMO Covered Call Health Care ETF (CAD)

ETF | Others |

Last Closing

CAD 30.58

Change

+0.37 (+1.22)%

Market Cap

N/A

Volume

300.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.09 (+0.33%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.01 (-0.02%)

CAD 5.38B
XEQT:CA iShares Core Equity Portfolio

+0.07 (+0.21%)

CAD 5.22B
PHYS-U:CA Sprott Physical Gold Trust

-0.56 (-2.70%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.05 (+0.13%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.63 (-2.54%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.26 (-2.45%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.01 (-0.04%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

-0.01 (-0.01%)

CAD 2.68B

ETFs Containing ZWHC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.76% 42% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.76% 42% F 45% F
Trailing 12 Months  
Capital Gain 11.61% 35% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.61% 35% F 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.60% 46% F 41% F
Dividend Return 1.60% 45% F 33% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3.41% 87% B+ 95% A
Risk Adjusted Return 47.08% 69% C- 63% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.